Call For Your Free Consultation
(314) 963-9000

Defective Drugs

Filter by category

Is Your Online Pharmacy Safe?

Posted on September 28th, 2020

The U.S. The Food and Drug Administration has launched a national campaign called BeSafeRx to educate consumers on the dangers of online pharmacies. As drug costs continue to rise, many consumers are turning to online resources for their medications because of the convenience, as well as for the cost savings. The effort began following an… Read More


Novartis to Pay $642 million for Kickbacks, Medicare Schemes

Posted on August 7th, 2020

Novartis Pharmaceuticals Corporation has agreed to pay more than $642 million to settle two separate claims brought by the U.S. Department of Justice that the company violated the False Claims Act. According to the lawsuits filed against the pharmacy giant, Novartis hid behind charitable foundations to illegally funnel co-payments for Medicare patients taking two of… Read More


Missouri Courts Plan Re-Opening

Posted on July 29th, 2020

When coronavirus arrived in the United States in March, effects of the lockdown crippled both the public and private sectors. The nation’s court system was no exception, as in-person hearings and jury trials were halted across the country. Civil and criminal cases were delayed, leaving both plaintiffs and defendants in legal limbo for months.  For… Read More


Truvada Trial Affected by COVID-19

Posted on July 29th, 2020

As COVID-19 continues to impact in-person court action, bellwether trials for mass torts and other civil court cases will likely be postponed. These continuations include a bellwether trial previously slated to be heard next winter, in January 2022, against Gilead for damage done by anti-HIV drug Truvada, or PrEP. Currently, the court has ordered the… Read More


Truvada Litigation Update

Posted on March 31st, 2020

Truvada litigation continues to move forward. Tuesday, March 31, 2020 – As we reported last month, the overall litigation is still in its early stages, and of course the COVID-19 pandemic has added its own complication with the California courts being closed at least through April 15, 2020. We have not yet been notified of an… Read More


Truvada Cases Moving Forward

Posted on March 5th, 2020

TDF litigation is in early stages. Thursday, March 5, 2020 – Litigation continues to move forward for plaintiffs who have suffered kidney, bone, and/or teeth issues after using Truvada and other drugs with the active ingredient tenofovir disoproxil fumarate (TDF). The OnderLaw Truvada litigation team has been working to obtain and review pharmacy and medical records… Read More


Congresswoman Urges FDA to Ban Zantac, Ranitidine Products

Posted on January 10th, 2020

Rosa DeLauro (CT-03)has asked the FDA to remove all ranitidine-based products from shelves. Friday, January 10, 2020 – One congresswoman has led a push to ban Zantac and other ranitidine-based medications in the U.S. due to concerns that they are causing cancer. Heartburn drug Zantac and other products containing a drug called ranitidine have taken… Read More


Have You Purchased Infants’ Tylenol in the Last 5 Years?

Posted on January 10th, 2020

You can receive $2.15 per bottle purchased for up to 7 bottles. Friday, January 10, 2020 – If you have purchased Infants’ Tylenol between Oct. 2, 2014 and Jan. 6, 2020, you may be eligible for compensation under a $6.315 million settlement. A federal judge approved the settlement after a class action suit that accused Johnson &… Read More


Activists Say Gilead Delayed Safer Version of PrEP

Posted on January 6th, 2020

There is no question that PrEP has saved lives. At issue is Gilead’s strategy to exploit consumers financially and physically for the sake of profits. Monday, January 6, 2020 – PrEP4All Collaboration, an activist group whose goal is to ensure HIV prevention meds are affordable and available to those who need them most, has filed a petition… Read More


Zantac Recalled for Carcinogen Contamination

Posted on December 18th, 2019

Popular heartburn medication Zantac has been pulled from the shelves of pharmacies and other suppliers following a US Food and Drug Administration (FDA) warning that the pills may be contaminated with NDMA, a toxic chemical and probable carcinogen. Wednesday, December 18, 2019 – Zantac manufacturer Sanofi recalled the drug in September 2019, three months after online pharmacy… Read More


It's not just a case, it's your life.

Talk to a Lawyer for Free

What is Your Case Worth?